Lung cancer is a deadly form of cancer and is responsible for many deaths worldwide. More than two million cases of lung cancer are diagnosed annually. This increasing incidence of the disease…
Author: Lung Cancer
How Lung Cancer Affects Quality of Life
Lung cancer remains the leading cause of cancer-related deaths worldwide. Patients with lung cancer often experience multiple symptoms associated with the disease as well as during the treatment process. The adverse effects…
Lung Cancer Risk Factors in Adults with Interstitial Lung Disease
Interesting Lung Diseases (ILDs) are characterized by pathological changes in Pulmonary parenchyma. It is a group of conditions that cause inflammation in the lungs. This can be caused by medication, radiation therapy…
Cooking Fumes and Lung Cancer – What’s the Association?
Over the past few years, lung cancer no longer remains among men only but is also on the rise among women. This is primarily due to shifts in smoking habits and environmental…
High-Dose Aumoltertinib for Untreated EGFR- Variant NSCLC
Aumoltertinib is a third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and has achieved potent efficacy for advanced EGFR-mutated non-small cell lung cancer patients. Phase 2 non-randomized clinical trial was conducted at…
Taletrectinib Received FDA Approval for ROS1-Positive NSCLC
Recently, FDA has granted approval to Taletrectinib for treatment of locally advanced or metastatic ROS1-positive non-small cell lung cancer in adults. Taletrectinib has demonstrated high response rates and was well tolerated among…
Study: New Nanoparticles Therapy for Lung Cancer Patients
A new research led by Gaurav Sahay of Oregon State University’s College ir Pharmacy was conducted in collaboration with Oregon Health & Science University and the University of Helsinki. In this study,…
Tarlatamab Shows Improved Overall Survival Over Chemotherapy in SCLC
Tarlatamab received accelerated approval for treatment of patients with previously treated small-cell lung cancer. It meaningfully improved overall survival compared with Chemotherapy in SCLC patients that progressed on or after initial platinum-based…